Furthermore, the absence of MMP9 compromises the invasive capabilities of tumors, solidifying MMP9’s position as not only a marker for CRC aggressiveness but also as a promising target for therapeutic intervention (Mudatsir et al., 2023). The gene discussed is MMP9; the disease is colorectal carcinoma.